Status:
COMPLETED
An Assessment of the Glyconutrient Ambrotose™ on Immunity, Gut Health, and Safety in Men and Women
Lead Sponsor:
University of Memphis
Collaborating Sponsors:
Mannatech, Inc
Conditions:
Healthy
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
This study evaluates the impact of two Ambrotose products on immunity, gut health, and associated measures in healthy men and women. Subjects are randomly assigned in double-blind manner to one of fiv...
Detailed Description
The product Ambrotose, which contains a blend of glyconutrients, has been used by human subjects for several years. It has been shown to enhance immunity, improve cognitive performance, and enhance an...
Eligibility Criteria
Inclusion
- must be physically active by participating in structured exercise at least twice per week for 30 or more minutes per session;
- not be pregnant
Exclusion
- diagnosed cardiovascular disease
- diagnosed metabolic disease
- diagnosed neurological disease
- using nutritional supplements or medications known to impact immunity or gut health
Key Trial Info
Start Date :
August 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04386226
Start Date
August 15 2018
End Date
June 1 2019
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Nutraceutical and Dietary Supplement Research
Memphis, Tennessee, United States, 38152